BNN — BRAIN Biotech AG Share News
0.000.00%
- €63.36m
- €63.46m
- €50.22m
Brief: Brain Biotech And Sartorius To Jointly Research And Adapt Novel CRISPR Cas-Nucleases
Brief: BRAIN Biotech H1 Adj. EBITDA Down At EUR -2.0 Mln
Brief: Brain Biotech Expands Stake In Biocatalysts Ltd
Brief: Brain First Development Phase For Novel Genome Editing Tool Completed (CRISPR Cas)
Brief: Brain AG Q1 Adjusted EBITDA Loss Widens To EUR 1.4 Million
Brief: Brain AG FY Adjusted EBITDA Loss Narrows To EUR 2.0 Million
Brief: BRAIN Group And Roquette Agree On Production Scale-Up For Protein Sweetener
Brief: B.R.A.I.N. Group Announces Successful Acquisition Of Biosun Biochemicals Inc.
Brief: Brain Presents New Strategy At Capital Markets Day
Brief: BRAIN Biotechnology Research And Information Network 9M Revenues At EUR 29.6 Mln
Brief: B.R.A.I.N. Buys Outstanding 24.7% Minority Stake Of WeissBioTech
Brief: BRAIN Completes Cash Capital Increase
Brief: BRAIN Resolves On Cash Capital Increase
Brief: BRAIN H1 EBITDA Loss Narrows To EUR 0.9 Million
Brief: BRAIN AG Says Lukas Linnig To Replace Manfred Bender As CFO
Brief: BRAIN AG Q1 Adjusted EBITDA Loss Widens To EUR 0.2 Million
Brief: BRAIN Expands Production Capacities
Brief: B.R.A.I.N. Appoints Adriaan Moelker As New CEO
Brief: BRAIN 9-Month EBITDA At EUR -2.3 Mln